Collectively, by using the 3D organoid model, we show that fibroblast-derived EVs transport AREG and they increase the number of proliferating CRC cells in patient-derived organoid lines that are dependent on external EGF activity, but not in an EGF-independent model system. The gene discussed is AREG; the disease is colorectal carcinoma.